Targeting ageing: the next frontier in drug delivery systems
Aging Pathobiology and Therapeutics · 25.06.2026 · 8 (2)
DOI: 10.31491/apt.2026.06.222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, online erschienen am 30.06.2026. Verfasst von Pratikeswar Panda und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Population ageing is rapidly reshaping healthcare systems worldwide, yet most drug delivery systems (DDS) continue to be designed using conventional models that inadequately reflect age-related physiological changes. Ageing is associated with progressive decline in tissue function, altered immune responses, and increased prevalence of chronic diseases, all of which significantly influence therapeutic outcomes. Emerging evidence suggests that biological hallmarks of ageing—including cellular senescence, chronic inflammation, mitochondrial dysfunction, and impaired tissue repair—directly affect drug absorption, distribution, and retention across multiple delivery routes. This commentary discusses how ageing-associated changes compromise the performance of oral, transdermal, ocular, and pulmonary drug delivery systems. Reduced gastrointestinal motility, dysphagia, skin barrier alterations, ocular degeneration, and declining pulmonary function collectively limit the effectiveness of conventional formulations in older adults. Recent advances in sustained-release formulations, biodegradable implants, nanocarriers, and senescence-targeted delivery platforms provide new opportunities to address these challenges. However, elderly populations remain significantly underrepresented in formulation development and clinical translation. We argue that ageing should no longer be treated as a secondary variable in pharmaceutical design. Instead, future DDS development must incorporate age-associated biological mechanisms to create personalized, adaptive, and safer therapeutic strategies for growing elderly populations. Keywords : Ageing, drug delivery systems, cellular senescence, nanomedicine, elderly therapeutics, precision medicine
Zitieren
APA
Panda, P., & Mohapatra, R. (2026). Targeting ageing: the next frontier in drug delivery systems. Aging Pathobiology and Therapeutics, 8(2). https://doi.org/10.31491/apt.2026.06.222
Vancouver
Panda P, Mohapatra R. Targeting ageing: the next frontier in drug delivery systems. Aging Pathobiology and Therapeutics. 2026;8(2). doi:10.31491/apt.2026.06.222
BibTeX
@article{Panda2026,
author = {Panda, Pratikeswar and Mohapatra, Rajaram},
title = {Targeting ageing: the next frontier in drug delivery systems},
journal = {Aging Pathobiology and Therapeutics},
year = {2026},
volume = {8},
number = {2},
doi = {10.31491/apt.2026.06.222}
}
EUVIMED